Connect your AI

Aurinia Pharmaceuticals AUPH Accrued interest

Accrued interest at other companies

Mirum Pharmaceuticals, Inc.MIRM

$5.27M0.0%

Ligand PharmaceuticalsLGND

$2.19M—

Ionis PharmaceuticalsIONS

$26.04M—

BridgeBio PharmaBBIO

——

Other financials

Income statement

Revenue$77.7M+24.4%

Gross profit$71.2M+32.1%

Operating income$41.4M+89.6%

Net income$34.4M+47.2%

EPS (diluted)$0.25+56.3%

Balance sheet

Cash & equivalents$41.0M-38.3%

Total debt$85.2M-7.9%

Total equity$567.6M+62.1%

Total assets$724.0M+43.4%

Cash flow

Operating cash flow$32.6M+2,405%

Valuation

Market cap$2.39B+78.5%

Profitability

Gross margin89.7%+1.5pp

Operating margin41.7%+29.4pp

Net margin100%+83.9pp

Returns & leverage

Return on equity65%+53.8pp

Debt / equity0.2×-0.1×

Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:InterestReceivable.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's accrued interest.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Aurinia Pharmaceuticals's accrued interest?: Aurinia Pharmaceuticals (AUPH) reported accrued interest of $700K in Q1 2026.
How has Aurinia Pharmaceuticals's accrued interest changed year-over-year?: Aurinia Pharmaceuticals's accrued interest increased by 250.0% year-over-year, from $200K to $700K.
What is the long-term trend for Aurinia Pharmaceuticals's accrued interest?: Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's accrued interest has grown at a 7.0% compound annual growth rate (CAGR), from $500K to $700K.
What does accrued interest mean?: Interest expense accrued but not yet paid on outstanding debt obligations, based on contractual interest rates and time elapsed.